Having a look through the other presenters at the Aus-China...

Having a look through the other presenters at the Aus-China conference.

ResApp is certainly a standout as it is so different to all of the others.

One interesting presenter however is Petri Exchange : this is their profile



Petri Exchange Petri Exchange is an Australian is a biotechnology corporate advisory specialist founded in 2016. Combining expertise in translational research, finance and accounting, Petri Exchange’s vision is to connect both private and public investors with late stage commercialised medical research opportunities via an online exchange. We connect investors with commercial opportunities from the best medical research and support both the researcher and investor to navigate the complexities of research commercialisation. Petri Exchange ensures medical research commercialisation opportunities are investor-ready, and provides supporting services throughout the investment lifecycle. Current project partners include some of Australia’s leading research institutes with our project pipeline covering a wide range of therapeutic areas. We are looking to work with investors who are interested in biotechnology investments, as well as researchers who wish to take advantage of the new suite of private sector commercialisation incentives.


Of course, once the American big boys get a taste for ResApp then Petri would be swamped if they got close.
But presenting in China? hummmmm